MDT

99.5

-0.24%↓

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

MDT

99.5

-0.24%↓

147.28

+1.07%↑

VEEV

244.14

+1.84%↑

HQY

97.26

0%↓

PHR.US

17.07

-2.68%↓

Kodu・Aktsiate loetelu・Evolent Health Inc

Evolent Health Inc

Avatud

SektorTervishoid

4.18 5.56

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.06

Max

4.25

Põhinäitajad
By Trading Economics
Sissetulek	30M -21M
Müük	35M 480M
Kasumimarginaal	-4.351
Töötajad	4,500
EBITDA	512K 15M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+142.17% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	19. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	-321M 458M
Eelmine avamishind	-1.38
Eelmine sulgemishind	4.18

Uudiste sentiment

By Acuity

34%

66%

106 / 372 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

10.33 / 10.95 Toetus ja vastupanu

Evolent Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. jaan 2026, 23:11 UTC

Tulu

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7. jaan 2026, 22:55 UTC

Suurimad hinnamuutused turgudel

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7. jaan 2026, 21:39 UTC

Suurimad hinnamuutused turgudel

Raytheon Down Following Trump Post Criticizing Company

7. jaan 2026, 20:13 UTC

Suurimad hinnamuutused turgudel

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7. jaan 2026, 20:03 UTC

Suurimad hinnamuutused turgudel

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7. jaan 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. jaan 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7. jaan 2026, 23:42 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7. jaan 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7. jaan 2026, 23:29 UTC

Omandamised, ülevõtmised, äriostud

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7. jaan 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7. jaan 2026, 22:46 UTC

Tulu

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7. jaan 2026, 22:45 UTC

Tulu

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7. jaan 2026, 22:43 UTC

Omandamised, ülevõtmised, äriostud

Revolution Medicines Draws Takeover Interest -- 2nd Update

7. jaan 2026, 22:42 UTC

Tulu

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7. jaan 2026, 22:41 UTC

Tulu

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7. jaan 2026, 22:41 UTC

Tulu

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7. jaan 2026, 22:40 UTC

Suurimad hinnamuutused turgudel

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7. jaan 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7. jaan 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7. jaan 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. jaan 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7. jaan 2026, 21:22 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7. jaan 2026, 21:18 UTC

Omandamised, ülevõtmised, äriostud

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7. jaan 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7. jaan 2026, 20:29 UTC

Omandamised, ülevõtmised, äriostud

AbbVie Near Deal for Revolution Medicines -- Update

7. jaan 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7. jaan 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7. jaan 2026, 19:48 UTC

Suurimad hinnamuutused turgudel

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Võrdlus sarnastega

Hinnamuutus

Evolent Health Inc Prognoos

Hinnasiht

By TipRanks

142.17% tõus

12 kuu keskmine prognoos

Keskmine 10.05 USD 142.17%

Kõrge 16 USD

Madal 7 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Evolent Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

Osta

Hoia

Müü

Põhineb 13 analüütiku instrumendi Evolent Health Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

10.33 / 10.95Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

106 / 372 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.